4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 4
Accession 0000950170-24-114802
CIK 0002022626other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 7:21 PM ET
Size
7.2 KB
Accession
0000950170-24-114802
Insider Transaction Report
Form 4
Transactions
- Conversion
Series B redeemable convertible preferred stock
2024-10-15−852,940→ 0 total→ Common Stock (894,733 underlying) - Conversion
Common Stock
2024-10-15+894,733→ 894,733 total
Footnotes (1)
- [F1]Each share of Series B redeemable convertible preferred stock automatically converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Series B redeemable convertible preferred stock had no expiration date.
Documents
Issuer
Upstream Bio, Inc.
CIK 0002022626
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001903360
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 7:21 PM ET
- Size
- 7.2 KB